Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.
about
Vitamin D in the cancer patientModeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cellsAnimal models of peripheral neuropathy due to environmental toxicantsTherapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia.Targeting DNA repair pathways for cancer treatment: what's new?Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer.Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.Methylmalonic Acid and Homocysteine as Indicators of Vitamin B-12 Deficiency in CancerMeasuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment ScaleEffect of Vitamin E on Oxaliplatin-induced Peripheral Neuropathy Prevention: A Randomized Controlled Trial.Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies.Neurological Adverse Effects in Patients of Advanced Colorectal Carcinoma Treated with Different Schedules of FOLFOXOxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy.Chemotherapy induced peripheral neuropathic painCurrent use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB.Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin-evoked peripheral neuropathy.Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).Management of peripheral neuropathy induced by chemotherapy in adults with cancer: a review.Histamine H4 receptor agonist-induced relief from painful peripheral neuropathy is mediated by inhibition of spinal neuroinflammation and oxidative stress.Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathy.Evaluation of the treatment of chronic chemotherapy-induced peripheral neuropathy using long-wave diathermy and interferential currents: a randomized controlled trial.Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer.Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source.Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency.A Systematic Review of Herbal Medicine for Chemotherapy Induced Peripheral Neuropathy.
P2860
Q27006469-F4413D79-FE7D-4DED-B9E5-8C4141A497A0Q27314983-87A88B01-5B8C-4F28-B849-754A9078BE3CQ28394003-42D02E69-165F-461E-8783-28ACA7FD9485Q33952803-31BB75FD-828A-418A-95E8-D90D3BDA6346Q34015040-38B5846C-CE03-417B-9555-764F556209BAQ35002187-C3E08D5F-C619-4FFC-B94A-433AFB8CCFB9Q35596252-EF119091-0A94-4D44-8255-21F7A2719FEAQ35903161-EFD32604-10B4-4629-93C6-447C0B1D1FD6Q36117942-2B7D2CB6-72CA-4019-92A2-9ADEA1D0CDBFQ36350645-C654E5A8-04DE-4044-AFC5-68EA4842BF01Q37168753-6C09D112-ECF7-41DF-B8B2-376A980CCED0Q37244795-1C506F1B-FBF3-4566-A26F-2E4D676FCB58Q37541146-FB19F2BB-2521-4E14-9860-ED08D8CB2179Q38237393-550A4A2E-6F6D-4119-B047-0B0139B8F825Q38254351-76A5643C-AA12-4001-81A7-4A8CBFF24FC7Q38582633-EDDC5986-44E2-497E-A17C-05EEB8F3C4BFQ38719679-EE120619-633C-46F2-AE7A-5D2B1C4779C6Q38722948-1674C830-9854-46A8-935B-E707EEF5383CQ38993256-05B9DCB9-902F-4C14-88AD-7BF53547223EQ39166397-A50E601D-2299-4995-ACB6-D06C8E5FB84AQ39289330-B89812AB-CA15-4843-A4B0-7E341A17A89CQ39406087-EC004596-84AC-441B-91EA-7EED3CC8523CQ50237975-7214E4EB-A97F-44A4-A57B-063749CDE5B6Q50250068-91EA4C62-3912-456A-855E-45C18ABD2736Q50560002-77F3E1D9-9A21-4234-819A-F5BF8499DF99Q52693014-1101E108-F6CC-4062-ADB4-ADDD5207732DQ53549443-3762A09F-ADD3-43AB-BC17-097EAB41E83CQ55334538-6BFF8699-3D64-41D1-A5CD-FD23C7500AFA
P2860
Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Nutraceuticals and chemotherap ...... y (CIPN): a systematic review.
@ast
Nutraceuticals and chemotherap ...... y (CIPN): a systematic review.
@en
Nutraceuticals and chemotherapy induced peripheral neuropathy
@nl
type
label
Nutraceuticals and chemotherap ...... y (CIPN): a systematic review.
@ast
Nutraceuticals and chemotherap ...... y (CIPN): a systematic review.
@en
Nutraceuticals and chemotherapy induced peripheral neuropathy
@nl
prefLabel
Nutraceuticals and chemotherap ...... y (CIPN): a systematic review.
@ast
Nutraceuticals and chemotherap ...... y (CIPN): a systematic review.
@en
Nutraceuticals and chemotherapy induced peripheral neuropathy
@nl
P2093
P1433
P1476
Nutraceuticals and chemotherap ...... y (CIPN): a systematic review.
@en
P2093
Anthony W Linnane
Caroline Airey
Janet M Schloss
Luis Vitetta
Paul P Masci
P304
P356
10.1016/J.CLNU.2013.04.007
P577
2013-04-13T00:00:00Z